Share on StockTwits

Research Analysts’ ratings reiterations for Monday, August 18th:

Cabelas (NYSE:CAB) had its neutral rating reiterated by analysts at Zacks. They currently have a $62.00 target price on the stock.

Central Garden (NASDAQ:CENT) had its neutral rating reissued by analysts at Zacks. The firm currently has a $8.85 price target on the stock.

Deutsche Bank (NYSE:DB) had its neutral rating reissued by analysts at Zacks. The firm currently has a $35.00 price target on the stock. Zacks’ analyst wrote, “Deutsche Bank reported lower second-quarter 2014 net earnings as compared with the prior-year period. Results were adversely affected by a deteriorating top line. However, decreased expenses, lower provision for credit losses and a strong capital position were the positives. Amid the worldwide economic volatility, the company is focused on building its capital level. Strategy 2015+ efforts are encouraging and we expect such efforts to help improve its operating efficiency. However, given the stressed operating environment, we do not expect any significant improvement in earnings in the coming quarters. Further, increased litigation costs are impacting the bank’s profitability Deutsche Bank might have to combat tough times ahead. “

D.R. Horton (NYSE:DHI) had its neutral rating reaffirmed by analysts at Zacks. Zacks currently has a $22.00 price target on the stock. Zacks’ analyst wrote, “D.R. Horton’s adjusted earnings of $0.32 per share in the third quarter of 2014 missed the Zacks Consensus Estimate by 34.7% and declined 23.8% year over year. Higher incentives, reduced gross margins, higher SG&A ratio and massive inventory/land impairment charges in the Chicago market hurt quarterly earnings. In an effort to improve the sales pace in the quarter, management increased incentives. Though the strategy improved order trends in the quarter, it took a toll on gross margins. Despite the poor quarterly results, we have faith in the company’s strong fundamentals which include its broad geographic footprint, product diversity and strong land position. We, therefore, have a Neutral recommendation on the stock”

Estee Lauder Companies (NYSE:EL) had its neutral rating reissued by analysts at Zacks. Zacks currently has a $80.00 price target on the stock. Zacks’ analyst wrote, “Estee Lauder’s fourth-quarter fiscal 2014 earnings of $0.45 missed the Zacks Consensus Estimate by 20%. Earnings, however, went up 83% year over year due to higher revenues. Net sales climbed 5% year over year and inched past the Zacks Consensus Estimate backed by strong results in all the categories. Sales were on the upswing as most of the product categories performed well in all the geographical regions. We commend the company’s aggressive marketing investment coupled with continued product innovation which is expected to boost sales in the coming quarters. Further, the company’s fast expansion into emerging markets is expected to insulate it from the ongoing macroeconomic challenges in the western countries. However, the difficult consumer spending environment continues, which keeps us on the sidelines with a Neutral rating “

The Kroger (NYSE:KR) had its neutral rating reaffirmed by analysts at Goldman Sachs.

Merck & Co. (NYSE:MRK) had its neutral rating reiterated by analysts at Zacks. The firm currently has a $62.00 price target on the stock. Zacks’ analyst wrote, “Merck’s second quarter earnings of $0.85 per share were above the Zacks Consensus Estimate of $0.81 and up 1.2% y-o-y. Revenues, while down 1% y-o-y, surpassed the Zacks Consensus Estimate. Cost control efforts helped the company record earnings growth. Going forward, we remain concerned about the performance of Januvia, which declined y-o-y. With Singulair and a few other products facing generic competition, we expect the top-line to remain under pressure. Merck will continue to look toward cost-cutting initiatives and share buybacks to drive the bottom-line. We are also positive on Merck’s efforts to expand its pipeline and focus on core areas of expertise. With the Idenix acquisition, Merck will boost its HCV portfolio. We remain Neutral on the stock.”

VeriFone Systems (NYSE:PAY) had its neutral rating reissued by analysts at Zacks. They currently have a $36.00 target price on the stock.

Perrigo Company PLC (NASDAQ:PRGO) had its neutral rating reissued by analysts at Zacks. Zacks currently has a $156.00 target price on the stock. Zacks’ analyst wrote, “Perrigo performed well in the fourth quarter of fiscal 2014, beating both on sales and earnings. The company’s fourth-quarter fiscal 2014 earnings of $1.74 per share beat the Zacks Consensus Estimate of $1.55. Higher-than-expected revenues led to the earnings beat. Moreover, fourth quarter earnings were 11% above the year-ago figure. Net sales in the quarter climbed 18% to $1.14 billion. Revenues were above the Zacks Consensus Estimate of $1.09 billion. For fiscal 2014, Perrigo reported earnings of $6.39 per share up 14%. The company expects fiscal 2015 adjusted earnings per share in the range of $7.20 to $7.50. We maintain our Neutral view on the stock. Our target price is $156.00 per share. “

Quality Systems (NASDAQ:QSII) had its neutral rating reaffirmed by analysts at Zacks. They currently have a $16.00 price target on the stock. Zacks’ analyst wrote, “Quality Systems continue to report a fall in earnings. In the recently completed first quarter-fiscal 2015, the company’s earnings plunged 50.0% to $0.12, in line with the Zacks Consensus Estimate but revenues of $117.9 million rose 7.6% and beat the Zacks Consensus Estimate by roughly $3 million. However, we are optimistic about Quality Systems given the continued strength in its NextGen division as well as the expected benefit from its Mirth acquisition. As such, we continue with our Neutral recommendation on Quality Systems and set a target price of $16.00.”

Reliance Steel & Aluminum (NYSE:RS) had its neutral rating reissued by analysts at Zacks. Zacks currently has a $72.00 price target on the stock.

Companhia Siderurgica Nacional (NYSE:SID) had its neutral rating reissued by analysts at Zacks. The firm currently has a $4.75 price target on the stock. Zacks’ analyst wrote, “CSN’s net income in second-quarter 2014 came in at R$19 million, down significantly year over year. Earnings were $0.01 per ADR. Revenues edged down 0.2% due to revenue declines in Steel and Logistics segments. Steel sales volume was down 20%, including 4% decline in domestic sales and 1% fall in exports. Demand for steel was feeble in the automotive and home appliances end markets. However, iron ore sales volume rose 20%. Expected economic growth across the world has rekindled our confidence about the future growth prospects of the steel industry. Also, CSN seems focused on improving its production capacity. However, factors like rising cost of sales, growing competition and currency translation may prove detrimental to growth. Thus, we maintain our Neutral recommendation on CSN.”

Sun Life Financial (NYSE:SLF) had its neutral rating reissued by analysts at Zacks. The firm currently has a $39.00 target price on the stock. Zacks’ analyst wrote, “Sun Life Financial’s second-quarter earnings grew year over year led by strong business growth, improving core earnings power and continued execution of the company’s four-pillar strategy. The company has been performing strongly over the past several quarters and we expect the trend to continue given its diversified business profile. Though headquartered in Canada, the insurer has a significant presence in the U.S., and is also growing in Asia. The company has been aggressively re-designing its products, reducing interest rate and market risk, improving pricing, and focusing on higher growth and return segments. Further, its alignment of product mix in the U.S. and thrust on enhancing the highly profitable global asset management business is expected to drive long-term earnings growth. Nevertheless, the company will continue facing earnings pressure due to headwinds such as the ongoing macro and regulatory uncertainty, and growing expenses. We thus maintain our Neutral recommendation on Sun Life. “

Receive News & Ratings for Cabelas Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabelas Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.